Latest Drug Approvals news
FDA Approves More Broadly Protective Meningococcal Vaccine
posted February 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
posted February 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
posted January 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD 
Healthy Lifestyle in Early Childhood Linked to Lower Risk for IBD 
Lung Disease More Common With Ulcerative Colitis Than Crohn Disease 
Heat-Not-Burn Tobacco, E-Cigarettes May Be Linked to Postoperative Recurrence of Crohn Disease Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
